Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason J Schafer

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Pharmaceutical Education|August 25, 2012
A root cause analysis project in a medication safety courseJason J Schafer
Pharmacotherapy|April 18, 2015
Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection - an alternative viewpointJason J Schafer
Expert Review of Anti-Infective Therapy|October 14, 2008
Establishing the role of tigecycline in an era of antimicrobial resistanceJason J Schafer, Debra A Goff
The Annals of Pharmacotherapy|December 31, 2009
Integrase inhibitors: a novel class of antiretroviral agentsJason J Schafer, Kathleen E Squires
Emerging Infectious Diseases|March 8, 2008
Multidrug-resistant Acinetobacter baumannii osteomyelitis from IraqJason J Schafer, Julie E Mangino
Antiviral Therapy|August 11, 2012
Rilpivirine, a novel non-nucleoside reverse transcriptase inhibitor for the management of HIV-1 infection: a systematic reviewJason J Schafer, William R Short
Pharmacotherapy|April 5, 2013
Bone health and human immunodeficiency virus infectionJason J Schafer, Kristine Manlangit, Kathleen E Squires
AIDS (London, England)|December 24, 2014
Hepatitis B reverse seroconversion in a patient with well controlled HIV infection: a case report and a review of the literatureJason J Schafer, Danielle Formella, Joseph A Desimone
The Annals of Pharmacotherapy|August 1, 2019
The Incidence and Severity of Drug Interactions Before and After Antiretroviral Therapy Simplification in Treatment-Experienced Patients With HIV InfectionNicholas V Hastain, Aleena Santana, Jason J Schafer
Pharmacotherapy|September 30, 2010
Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virusJason J Schafer, William R Short, Kathleen E Squires
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Pharmaceutical Education|August 25, 2012
A root cause analysis project in a medication safety courseJason J Schafer
Pharmacotherapy|April 18, 2015
Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection - an alternative viewpointJason J Schafer
Expert Review of Anti-Infective Therapy|October 14, 2008
Establishing the role of tigecycline in an era of antimicrobial resistanceJason J Schafer, Debra A Goff
The Annals of Pharmacotherapy|December 31, 2009
Integrase inhibitors: a novel class of antiretroviral agentsJason J Schafer, Kathleen E Squires
Emerging Infectious Diseases|March 8, 2008
Multidrug-resistant Acinetobacter baumannii osteomyelitis from IraqJason J Schafer, Julie E Mangino
Antiviral Therapy|August 11, 2012
Rilpivirine, a novel non-nucleoside reverse transcriptase inhibitor for the management of HIV-1 infection: a systematic reviewJason J Schafer, William R Short
Pharmacotherapy|April 5, 2013
Bone health and human immunodeficiency virus infectionJason J Schafer, Kristine Manlangit, Kathleen E Squires
AIDS (London, England)|December 24, 2014
Hepatitis B reverse seroconversion in a patient with well controlled HIV infection: a case report and a review of the literatureJason J Schafer, Danielle Formella, Joseph A Desimone
The Annals of Pharmacotherapy|August 1, 2019
The Incidence and Severity of Drug Interactions Before and After Antiretroviral Therapy Simplification in Treatment-Experienced Patients With HIV InfectionNicholas V Hastain, Aleena Santana, Jason J Schafer
Pharmacotherapy|September 30, 2010
Association between abacavir exposure and increased risk for cardiovascular disease in patients with human immunodeficiency virusJason J Schafer, William R Short, Kathleen E Squires
Pageof 4